Efeitos farmacologicos e morfologicos do polietilenoglicol (PEG 400) em preparações neuromusculares / The influence of polyethylene glycol 400 (PEG) on the neuromuscular junction

AUTOR(ES)
DATA DE PUBLICAÇÃO

2009

RESUMO

Polyethyleneglycol has been widely used in several areas such as cosmetic, odontology and pharmaceutical (even as drugs carrier) due to its chemical properties. Thus, it is considered a bioactive molecule being its internal consumption approved by the Food and Drug Administration (FDA). The aim of this study was to analyze the pharmacological effects of PEG 400 over the neuromuscular junction through experimental observations in mice preparations due to the increase of the contractile response amplitude (facilitating effect). Conventional myographic techniques, morphological and electrophysiological analysis were used in mice, phrenic nerve diaphragm preparations (PND) and chick, biventer cervicis preparations (BC). Concentrations of 3 µM, 20 µM and 100 µM of PEG 400, d-Tc 6 µM, neostigmine 12 µM and dantrolene 30 µM helped in the search for the understanding of PEG mechanism. Specifically, the action of PEG 400 was investigated over the nervous terminal, the synaptic cleft, nicotinic receptors or muscle fiber. The results obtained through the electrophysiological technique showed that PEG 400 did not exhibit pre-synaptic action and did not act as an anticholinesterasic, as well as neostigmine. It has not presented action over nicotinic receptors but it presented post-synaptic action, interfering on the sarcolemma polarity and reverting the action of the Calcium antagonist, dantrolene, suggesting an interference of the contraction mechanism through Calcium and the ryanodine receptor. Finally, PEG 400 did not cause mionecrosis (3 µM and 20 µM) even in concentrations high enough to cause total muscle blockade (100 µM)

ASSUNTO(S)

solventes neuromuscular junction junção neuromuscular solvent polyethylene glycol polietileno glicol

ACESSO AO ARTIGO

Documentos Relacionados